A comprehensive view of biopharmaceuticals/biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bristol Myers partners with biotech firm SyntheX to discover, develop, commercialize novel small molecular glue degraders using SyntheX's ToRNeDO platform for protein degradation; SyntheX eligible for up to US$550.0M is milestone payments

California Institute for Regenerative Medicine sets up support program to help patients participate in clinical trials, with an emphasis on helping underserved populations; program expected to cost between US$300,000 – US$500,000 annually

Citius Pharmaceuticals partnering with University of Pittsburg, University of Minnesota in I/ONTAK clinical studies; I/ONTAK is recombinant fusion protein that combines interleukin-2 receptor binding domain with diphtheria toxin fragments

BioMarin Pharmaceutical resubmits application to FDA for approval of injectable gene therapy valoctocogene roxaparvovec to treat severe hemophilia; if approved, the drug would be first commercially-available gene therapy in US to treat the condition

Vertex licenses Maxcyte’s ExPERT cell engineering platform to develop experimental gene-edited therapy exa-cel, previously known at CXT001; Maxcyte to receive undisclosed licensing fee, program-related revenue

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count